$CNS Pharmaceuticals(CNSP)$ S-1 General form for registration of securities under the Securities Act of 1933 Accession Number: 0001683168-23-008734 Act: 33 Size: 1 MB 网页链接
$CNS Pharmaceuticals(CNSP)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-23-003505 Act: 33 Size: 1 KB 网页链接
$CNS Pharmaceuticals(CNSP)$ 424B3 Prospectus [Rule 424(b)(3)] Accession Number: 0001683168-23-008578 Act: 33 Size: 103 KB 网页链接
$CNS Pharmaceuticals(CNSP)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001683168-23-008407 Act: 33 Size: 59 KB 网页链接
$CNS Pharmaceuticals(CNSP)$ S-3 Registration statement under Securities Act of 1933 Accession Number: 0001683168-23-008367 Act: 33 Size: 185 KB 网页链接
$CNS Pharmaceuticals(CNSP)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001683168-23-008159 Act: 34 Size: 235 KB 网页链接
$CNS Pharmaceuticals(CNSP)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001683168-23-008144 Act: 34 Size: 2 MB 网页链接
$CNS Pharmaceuticals(CNSP)$ 8-K Current report, item 7.01 Accession Number: 0001683168-23-007238 Act: 34 Size: 201 KB 网页链接
$CNS Pharmaceuticals(CNSP)$ 8-K Current report, items 1.01, 3.02, and 9.01 Accession Number: 0001683168-23-007207 Act: 34 Size: 449 KB 网页链接
$CNS Pharmaceuticals(CNSP)$ 4/A [Amend] Statement of changes in beneficial ownership of securities Accession Number: 0001683168-23-007107 Size: 5 KB 网页链接